ANTICARDIOLIPIN - ANVISA Registration 10259610041

Access comprehensive regulatory information for ANTICARDIOLIPIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610041 and manufactured by GENBIO. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, PHADIA AB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610041
Registration Details
ANVISA Registration Number: 10259610041
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ANTICARDIOLIPINA M
Risk Class II

Registration Details

10259610041

25351055843200345

68814961000173

Company Information

GENBIO
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Mar 17, 2004

VIGENTE

09/18/2025 19:00:01